COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT04119453
Brief Title: Phase 2 Study to Evaluate the Efficacy and Safety of Rivoceranib in Subjects With Recurrent or Metastatic ACC

First Submitted : September 24, 2019
First Submitted that Met QC Criteria : October 7, 2019
First Posted : October 8, 2019

Last Update Submitted that Met QC Criteria : July 26, 2020
Last Update Posted : July 29, 2020